LLY vs TECH
By Alex · Tickerpine
Eli Lilly and Company vs Bio-Techne Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | TECH |
|---|---|---|
| Price | $1,273.46 | $72.55 |
| Market cap | $1.14T | $11.38B |
| P/E ratio | 42.7 | 62.5 |
| ROE | 102.29% | 9.03% |
| Profit margin | 33.53% | 14.97% |
| Revenue growth | 47.70% | 1.30% |
| Dividend yield | 0.54% | 0.44% |
| Beta | 0.45 | 1.29 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs TECH in plain English
- LLY is the bigger company — about 99.8× the market cap of TECH.
- LLY is cheaper on earnings (P/E 42.7 vs 62.5).
- LLY earns a higher return on equity (102% vs 9%).
- LLY is growing revenue faster (48% vs 1%).
- LLY has the higher dividend yield (0.54% vs 0.44%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
TECH return calculator
See what $1,000 in Bio-Techne Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.